Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
May 31, 2016 | Sep. 12, 2016 | Nov. 30, 2015 | |
Document and Entity Information [Abstract] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | May 31, 2016 | ||
Trading Symbol | beut | ||
Entity Registrant Name | Science to Consumers, Inc. | ||
Entity Central Index Key | 1,583,671 | ||
Current Fiscal Year End Date | --05-31 | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Public Float | $ 3,657,200 | ||
Entity Common Stock, Shares Outstanding | 31,920,000 | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Well Known Seasoned Issuer | No | ||
Document Fiscal Year Focus | 2,016 | ||
Document Fiscal Period Focus | FY |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | May 31, 2016 | May 31, 2015 |
Current Assets | ||
Cash and cash equivalents | $ 3,306 | $ 1,749 |
Total Current Assets | 3,306 | 1,749 |
Website development costs | 8,420 | |
Total Assets | 11,726 | 1,749 |
Current Liabilities | ||
Accounts payable and accrued liabilities | 16,857 | |
Due to related party | 7,675 | |
Loan from director | 8,891 | 8,891 |
Loan payable | 31,000 | |
Total Liabilities | 64,423 | 8,891 |
Stockholders' Deficit | ||
Common stock, par value $0.001; 525,000,000 shares authorized, 31,900,000 shares (2015 - 29,900,000 shares) issued and outstanding; | 31,900 | 29,900 |
Additional paid in capital | 59,100 | 61,100 |
Stock Subscriptions | 13,150 | |
Accumulated deficit | (156,847) | (98,142) |
Total Stockholders' Deficit | (52,697) | (7,142) |
Total Liabilities and Stockholders' Deficit | $ 11,726 | $ 1,749 |
BALANCE SHEETS (Parenthetical)
BALANCE SHEETS (Parenthetical) - $ / shares | May 31, 2016 | May 31, 2015 |
Balance Sheets Parenthetical | ||
Common Stock, Par Value | $ 0.001 | $ 0.001 |
Common Stock, Shares Authorized | 525,000,000 | 525,000,000 |
Common Stock, Shares Issued | 31,900,000 | 29,900,000 |
Common Stock, Shares Outstanding | 31,900,000 | 29,900,000 |
STATEMENTS OF OPERATIONS
STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
May 31, 2016 | May 31, 2015 | |
Statements Of Operations | ||
REVENUES | ||
OPERATING EXPENSES | ||
Advertising and Promotion | 8,800 | 15 |
Amortization Expense | 2,032 | |
General and Administrative | 25,012 | 16,262 |
Professional Fees | 22,483 | 32,819 |
TOTAL OPERATING EXPENSES | 58,327 | 49,096 |
NET LOSS FROM OPERATIONS | (58,327) | (49,096) |
OTHER EXPENSES | ||
Interest Expense | 378 | |
NET LOSS FROM OPERATIONS BEFORE TAXES | (58,705) | (49,096) |
Provision for Income Taxes | ||
NET LOSS | $ (58,705) | $ (49,096) |
NET LOSS PER OUTSTANDING SHARE: BASIC AND DILUTED | $ 0 | $ 0 |
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED | 30,813,000 | 29,900,000 |
STATEMENT OF STOCKHOLDERS' DEFI
STATEMENT OF STOCKHOLDERS' DEFICIT - USD ($) | Common Stock | Additional Paid-In Capital | Stock Subscriptions | Accumulated Deficit | Total |
Beginning Balance, Amount at May. 31, 2014 | $ 29,750 | $ 16,250 | $ (49,046) | $ (3,046) | |
Beginning Balance, Shares at May. 31, 2014 | 29,750,000 | ||||
Shares and warrants issued for cash at $0.30 per share, Amount | $ 150 | 44,850 | $ 45,000 | ||
Shares and warrants issued for cash at $0.30 per share, Shares | 150,000 | 150,000 | |||
Net loss | (49,096) | $ (49,096) | |||
Ending Balance, Amount at May. 31, 2015 | $ 29,900 | 61,100 | (98,142) | $ (7,142) | |
Ending Balance, Shares at May. 31, 2015 | 29,900,000 | ||||
Shares and warrants issued for cash at $0.30 per share, Shares | 150,000 | ||||
Common stock subscribed for cash at $0.30 per share, Amount | 13,150 | $ 13,150 | |||
Shares issued for license agreement, Amount | $ 2,000 | (2,000) | |||
Shares issued for license agreement, Shares | 2,000,000 | 2,000,000 | |||
Net loss | (58,705) | $ (58,705) | |||
Ending Balance, Amount at May. 31, 2016 | $ 31,900 | $ 59,100 | $ (13,150) | $ (156,847) | $ (52,697) |
Ending Balance, Shares at May. 31, 2016 | 31,900,000 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
May 31, 2016 | May 31, 2015 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss for the year | $ (58,705) | $ (49,096) |
Adjustments to reconcile net loss: | ||
Amortization | 2,032 | |
Changes in assets and liabilities: | ||
Accounts payable and accrued liabilities | 6,405 | |
Due to related parties | 2,575 | |
CASH FLOWS USED IN OPERATING ACTIVITIES | (47,693) | (49,096) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Advances from related party | 5,100 | |
Loans from director | 674 | |
Proceeds from loan payable | 31,000 | |
Proceeds from sale of common stock | 45,000 | |
Proceeds from common stock subscribed | 13,150 | |
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES | 49,250 | 45,674 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 1,557 | (3,422) |
Cash and cash equivalents, beginning of year | 1,749 | 5,171 |
Cash and cash equivalents, end of year | 3,306 | 1,749 |
SUPPLEMENTAL CASH FLOW INFORMATION: | ||
Interest paid | ||
Income taxes paid |
ORGANIZATION AND NATURE OF BUSI
ORGANIZATION AND NATURE OF BUSINESS | 12 Months Ended |
May 31, 2016 | |
Organization And Nature Of Business | |
1. ORGANIZATION AND NATURE OF BUSINESS | Science to Consumers, Inc. (the Company) is a development stage company registered in the State of Nevada on April 15, 2013 formed to distribute Argan Oil products. In addition, the Company is looking to market, sell, and distribute anti-aging products, as on December 29, 2015 the Company signed a five-year exclusive licensing agreement with Biomatrix, Inc. for the Peoples Republic of China and Europe. The agreement will allow Science to Consumers Inc., to market and sell at least six of its special formulated anti-aging products including the DermaLastyl line. The Company will position itself to take full advantage of the distributing its products from their manufacturers to their customers. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
May 31, 2016 | |
Summary Of Significant Accounting Policies | |
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. Accounting Basis The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (GAAP accounting). The Company has adopted a May 31 fiscal year end. Cash and Cash Equivalents The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $3,306 of cash as of May 31, 2016 and $1,749 of cash as of May 31, 2015. Fair Value of Financial Instruments The Companys financial instruments consist of cash and cash equivalents, accounts payable, amounts due to a related party, a loan from a director and a loan payable. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. Website Development Costs Website development costs consist of costs incurred to develop internet websites to promote, advertise, and earn revenue with respect to the Companys business operations. Costs are amortized on a straight line basis over 3 years from when the internet web site has been completed. Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Revenue Recognition The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured. Stock-Based Compensation Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options. Basic Income (Loss) Per Share Basic income (loss) per share is calculated by dividing the Companys net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Companys net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of May 31, 2016 and 2015. Comprehensive Income The Company has which established standards for reporting and display of comprehensive income, its components and accumulated balances. When applicable, the Company would disclose this information on its Statement of Stockholders Deficit. Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. The Company has not had any significant transactions that are required to be reported in other comprehensive income. Reclassifications Certain amounts in the fiscal 2015 financial statements have been reclassified to conform to the fiscal 2016 presentation, specifically classifications between bank service charges, general and administrative expenses and professional fees. |
GOING CONCERN
GOING CONCERN | 12 Months Ended |
May 31, 2016 | |
Going Concern | |
3. GOING CONCERN | The Company had no revenues as of May 31, 2016. The Company currently has accumulated deficit and working capital deficit, and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Accordingly, there is substantial doubt about the Companys ability to continue as a going concern. The accompanying financial statements have been prepared in conformity with generally accepted accounting principle, which contemplate continuation of the Company as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty. Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses The Company intends to position itself so that it may be able to raise additional funds through the capital markets. In light of managements efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern. |
LICENSE AGREEMENT
LICENSE AGREEMENT | 12 Months Ended |
May 31, 2016 | |
License Agreement | |
4. LICENSE AGREEMENT | On December 29, 2015, the Company entered into an exclusive license agreement with Biomatrix Inc. (Biomatrix), a Delaware corporation, pursuant to which the Company obtained the exclusive rights to sell certain proprietary skincare products of Biomatrix by direct to consumer marketing and sales in the territories of China and Europe. In consideration for the marketing, sales and distribution services to be provided by the Company, Biomatrix has agreed to supply product inventory at a rate not less favorable than that provided to any third party. Additionally, Biomatrix has agreed to transfer to the Company 100% equity ownership of Biomatrix Inc. (Biomatrix Arizona), an Arizona corporation, which holds all right and title to the product distribution rights acquired. In consideration of transfer of title and rights acquired, the Company issued 2,000,000 restricted shares of common stock to Biomatrix. Upon closing of the transaction, Biomatrix Arizona will become a wholly owned subsidiary of the Company. As of May 31, 2016, the transaction had not closed and the Company has not received ownership of the Biomatrix Arizona equity. The initial term of the exclusive license agreement is 5 years, subject to the Company achieving minimum sales of $250,000 and $500,000 during the first and second years of the agreement, respectively. Thereafter, the term will automatically renew for successive 5 year periods provided that the Company achieve a minimum $500,000 in sales of the licensed products during each calendar year of the term, excluding the first year. On December 16, 2015, the Company issued Biomatrix 2,000,000 shares of the Company common stock pursuant to the license agreement. As of May 31, 2016, the shares of Biomatrix Arizona were not received by the Company and the transaction had not closed. Due to the value of Biomatrix Arizona and the Company uncertain future revenues generated by the license, the fair value of the 2,000,000 shares issued has been recorded as $nil. |
DUE TO RELATED PARTY
DUE TO RELATED PARTY | 12 Months Ended |
May 31, 2016 | |
Due To Related Party | |
5. DUE TO RELATED PARTY | As of May 31, 2016, the Company was indebted to the Chief Executive Officer of the Company for $7,675 (2015 - $nil), for expenses paid on behalf of the Company. The amount is unsecured, non-interest bearing and due on demand. |
LOAN FROM DIRECTOR
LOAN FROM DIRECTOR | 12 Months Ended |
May 31, 2016 | |
Loan From Director | |
6. LOAN FROM DIRECTOR | As of May 31, 2016, the Company owed a director of the Company $8,891 (2015 - $8,891) related to a loan to the Company for business operations. The loan is unsecured, non-interest bearing and due on demand. |
LOAN PAYABLE
LOAN PAYABLE | 12 Months Ended |
May 31, 2016 | |
Loan Payable | |
7. LOAN PAYABLE | On May 1, 2016, the Company entered into a loan agreement in which the note holder agreed to provide a loan to the Company in the principal amount of up to $50,000. The loan is unsecured, bears interest at 8.5% per annum and payable on May 1, 2017. As at May 31, 2016, the note holder has provided $31,000 to the Company pursuant to the loan agreement. As at May 31, 2016, the Company recorded $188 of interest payable. |
COMMON STOCK
COMMON STOCK | 12 Months Ended |
May 31, 2016 | |
CommonStockAbstract | |
8. COMMON STOCK | The Company has 525,000,000, $0.001 par value shares of common stock authorized. On July 31, 2014, our company board of directors approved a resolution to effect a 7 new for 1 old forward split of our authorized and outstanding shares of common stock. A Certificate for the stock split was filed and became effective with the Nevada Secretary of State on August 19, 2014. Consequently, our authorized share capital increased from 4,250,000 to 29,750,000 shares, all with a par value of $0.001. On September 17, 2014, the Company issued 50,000 units for cash proceeds of $15,000 at $0.30 per unit. Each unit consisted of one share of common stock and one warrant. Each warrant entitles the holder to purchase one share of common stock at $0.50 per share on or before September 17, 2017. The grant date fair value of the warrants, determined using the Black-Scholes option pricing model, was $0.50 per share. On September 18, 2014, the Company issued 100,000 units for cash proceeds of $30,000 at $0.30 per unit. Each unit consisted of one share of common stock and one warrant. Each warrant entitles the holder to purchase one share of common stock at $0.50 per share on or before September 18, 2017. The grant date fair value of the warrants, determined using the Black-Scholes option pricing model, was $0.50 per share. On September 11, 2015, the Company received cash proceeds of $6,000 for 20,000 shares of common stock subscribed at $0.30 per share. On December 16, 2015, the Company issued 2,000,000 restricted shares to Biomatrix, Inc. with a fair value of $nil pursuant to the license agreement referred to Note 4. On December 16, 2015, the Company received cash proceeds of $4,650 for 15,500 shares of common stock subscribed at $0.30 per share. On January 20, 2016, the Company received cash proceeds of $2,500 for 8,333 shares of common stock subscribed at $0.30 per share. There were 31,943,833 shares of common stock issued and outstanding as of May 31, 2016. |
WARRANTS
WARRANTS | 12 Months Ended |
May 31, 2016 | |
Warrants | |
9. WARRANTS | The following table summarizes the continuity of share purchase warrants: Number of Warrants Weighted Average Exercise Price $ Balance, May 31, 2014 Issued 150,000 0.50 Balance, May 31, 2015 and 2016 150,000 0.50 As at May 31, 2016, the following share purchase warrants were outstanding: Number of Warrants Exercise Price $ Expiry Date Weighted Average Remaining Life (years) 50,000 0.50 September 17, 2017 1.30 100,000 0.50 September 18, 2017 1.30 150,000 1.30 |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 12 Months Ended |
May 31, 2016 | |
Commitments And Contingencies | |
10. COMMITMENTS AND CONTINGENCIES | The Company neither owns nor leases any real or personal property. An officer has provided office services without charge. There is no obligation for the officer to continue this arrangement. Such costs are immaterial to the financial statements and accordingly are not reflected herein. The officers and directors are involved in other business activities and most likely will become involved in other business activities in the future. |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
May 31, 2016 | |
Income Taxes | |
11. INCOME TAXES | As of May 31, 2016, the Company had net operating loss carry forwards of approximately $137,686 that may be available to reduce future years taxable income in varying amounts and begin expiring in 2032. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards. The provision for Federal income tax benefit attributable to: May 31, 2016 May 31, 2015 Federal income tax benefit attributable to: Net operating loss carryover $ 19,960 $ 16,693 Less: valuation allowance (19,960 ) (16,693 ) Net provision for Federal income taxes $ $ The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows: May 31, 2016 May 31, 2015 Deferred tax asset attributable to: Net operating loss carryover $ 47,208 $ 27,248 Less: valuation allowance (47,208 ) (27,248 ) Net deferred tax asset $ $ Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $137,686 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur net operating loss carry forwards may be limited as to use in future years. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
May 31, 2016 | |
Subsequent Events | |
12. SUBSEQUENT EVENTS | On September 1, 2016 the company signed an Exclusive Distributor Agreement signed with SHI TU KANG TRADING CO LTD., (STK ) with office located in Nan Sha district, Guangzhou China. STK is a privately owned cosmetics, health & beauty, fragrance, and personal care trading a distribution company. In order to leverage the infrastructure in place with STK as the company will rely on STKs support on sharing resources, office space and depending on their full assistance to customize packaging, boxes design, private label with Chinese brand name patent ( ) for the Chinese market. The agreement states that STK will commit to provide the full turnkey services to simply importing products with valid import license from Hong Kong via Hai Tao Base official platform to marketing S2C products to their existing sales channels such as beauty parlours, drugstores, WeChat shops, beauty chain stores and as well some of their existing online shops. In accordance with SFAS 165 (ASC 855-10) the Company has analyzed its operations subsequent to May 31, 2016 to the date these financial statements were issued. |
SUMMARY OF SIGNIFCANT ACCOUNTIN
SUMMARY OF SIGNIFCANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
May 31, 2016 | |
Summary Of Signifcant Accounting Policies Policies | |
Basis of Presentation | The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. |
Accounting Basis | The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (GAAP accounting). The Company has adopted a May 31 fiscal year end. |
Cash and Cash Equivalents | The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $3,306 of cash as of May 31, 2016 and $1,749 of cash as of May 31, 2015. |
Fair Value of Financial Instruments | The Company financial instruments consist of cash and cash equivalents, accounts payable, amounts due to a related party, a loan from a director and a loan payable. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. |
Website Development Costs | Website development costs consist of costs incurred to develop internet websites to promote, advertise, and earn revenue with respect to the Company business operations. Costs are amortized on a straight line basis over 3 years from when the internet web site has been completed. |
Income Taxes | Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. |
Use of Estimates | The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Revenue Recognition | The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured. |
Stock-Based Compensation | Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options. |
Basic Income (Loss) Per Share | Basic income (loss) per share is calculated by dividing the Company net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Companys net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of May 31, 2016 and 2015. |
Comprehensive Income | The Company has which established standards for reporting and display of comprehensive income, its components and accumulated balances. When applicable, the Company would disclose this information on its Statement of Stockholders Deficit. Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. The Company has not had any significant transactions that are required to be reported in other comprehensive income. |
Reclassifications | Certain amounts in the fiscal 2015 financial statements have been reclassified to conform to the fiscal 2016 presentation, specifically classifications between bank service charges, general and administrative expenses and professional fees. |
WARRANTS (Tables)
WARRANTS (Tables) | 12 Months Ended |
May 31, 2016 | |
Warrants Tables | |
Schedule of Share Purchase Warrants, Activity | Number of Warrants Weighted Average Exercise Price $ Balance, May 31, 2014 Issued 150,000 0.50 Balance, May 31, 2015 and 2016 150,000 0.50 |
Schedule of Purchase Warrants Outstanding | Number of Warrants Exercise Price $ Expiry Date Weighted Average Remaining Life (years) 50,000 0.50 September 17, 2017 1.30 100,000 0.50 September 18, 2017 1.30 150,000 1.30 |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
May 31, 2016 | |
Income Taxes Tables | |
Schedule of Provision for Federal Income Tax | May 31, 2016 May 31, 2015 Federal income tax benefit attributable to: Net operating loss carryover $ 19,960 $ 16,693 Less: valuation allowance (19,960 ) (16,693 ) Net provision for Federal income taxes $ $ |
Schedule of Deferred Tax Assets and Liabilities | May 31, 2016 May 31, 2015 Deferred tax asset attributable to: Net operating loss carryover $ 47,208 $ 27,248 Less: valuation allowance (47,208 ) (27,248 ) Net deferred tax asset $ $ |
SUMMARY OF SIGNIFICANT ACCOUN22
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | May 31, 2016 | May 31, 2015 |
Summary Of Significant Accounting Policies Details Narrative | ||
Cash and cash equivalents | $ 3,306 | $ 1,749 |
GOING CONCERN (Details Narrativ
GOING CONCERN (Details Narrative) - USD ($) | 12 Months Ended | |
May 31, 2016 | May 31, 2015 | |
Going Concern Details Narrative | ||
REVENUES |
LICENSE AGREEMENT (Details Narr
LICENSE AGREEMENT (Details Narrative) | 12 Months Ended |
May 31, 2016USD ($)shares | |
License Agreement Details Narrative | |
Shares issued for license agreement, Amount | $ | |
Shares issued for license agreement, Shares | shares | 2,000,000 |
DUE TO RELATED PARTY (Details N
DUE TO RELATED PARTY (Details Narrative) - USD ($) | May 31, 2016 | May 31, 2015 |
Due To Related Party Details Narrative | ||
Due to related party | $ 7,675 |
LOAN FROM DIRECTOR (Details Nar
LOAN FROM DIRECTOR (Details Narrative) - USD ($) | May 31, 2016 | May 31, 2015 |
Loan From Director Details Narrative | ||
Loan from director | $ 8,891 | $ 8,891 |
LOAN PAYABLE (Details Narrative
LOAN PAYABLE (Details Narrative) - USD ($) | May 31, 2016 | May 31, 2015 |
Loan Payable Details Narrative | ||
Loan payable | $ 31,000 | |
Interest payable | $ 188 |
COMMON STOCK (Details Narrative
COMMON STOCK (Details Narrative) - $ / shares | May 31, 2016 | May 31, 2015 |
Common Stock Details Narrative | ||
Common Stock, Par Value | $ 0.001 | $ 0.001 |
Common Stock, Shares Authorized | 525,000,000 | 525,000,000 |
Common Stock, Shares Issued | 31,900,000 | 29,900,000 |
Common Stock, Shares Outstanding | 31,900,000 | 29,900,000 |
WARRANTS (Details)
WARRANTS (Details) - $ / shares | 12 Months Ended | |
May 31, 2016 | May 31, 2015 | |
Warrants Details | ||
Number of Warrants, Biginning | 150,000 | |
Number of Warrants issued | 150,000 | 150,000 |
Number of Warrants, Ending | 150,000 | 150,000 |
Weighted Average Exercise Price, Beginning | $ 0.50 | |
Weighted Average Exercise Price issued | 0.50 | 0.50 |
Weighted Average Exercise Price, Ending | $ 0.50 | $ 0.50 |
WARRANTS (Details 1)
WARRANTS (Details 1) | 12 Months Ended |
May 31, 2016$ / sharesshares | |
Number of Warrants | 150,000 |
Weighted Average Remaining Life (years) | 1 year 3 months 18 days |
Warrant [Member] | |
Number of Warrants | 50,000 |
Exercise Price | $ / shares | $ 0.50 |
Expiry Date | September 17, 2017 |
Weighted Average Remaining Life (years) | 1 year 3 months 18 days |
Warrant One [Member] | |
Number of Warrants | 100,000 |
Exercise Price | $ / shares | $ 0.50 |
Expiry Date | September 18, 2017 |
Weighted Average Remaining Life (years) | 1 year 3 months 18 days |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) | 12 Months Ended | |
May 31, 2016 | May 31, 2015 | |
Federal income tax benefit attributable to: | ||
Net operating loss carryover | $ 19,960 | $ 16,693 |
Less: valuation allowance | (19,960) | (16,693) |
Net provision for Federal income taxes |
INCOME TAXES (Details 1)
INCOME TAXES (Details 1) - USD ($) | May 31, 2016 | May 31, 2015 |
Deferred tax asset attributable to: | ||
Net operating loss carryover | $ 47,208 | $ 27,248 |
Less: valuation allowance | (47,208) | (27,248) |
Net deferred tax asset |
INCOME TAXES (Details Narrative
INCOME TAXES (Details Narrative) | 12 Months Ended |
May 31, 2016USD ($) | |
Income Taxes Details Narrative | |
Net operating loss carry forwards | $ 137,686 |
expiry year | 2,032 |